Sunshield Chemicals Approves Draft Letter of Offer for Rights Issue Aug 06, 2025
More news about Sunshield Chemicals
31Jul 25
Sunshield Chemicals Approves Rs. 150 Crore Rights Issue and Restructures Board Committees
Sunshield Chemicals Limited's Board of Directors has approved a rights issue to raise up to Rs. 150.00 crores through equity shares. The company has also restructured its Audit, Nomination and Remuneration, and Stakeholders Relationship Committees, effective October 21, 2025. Mr. Mukesh Malhotra will chair all three committees. The Board approved unaudited financial results for the quarter ended June 30, 2025, with auditors issuing an unmodified report. The trading window for company securities will reopen 48 hours after the financial results declaration.
28Jul 25
Sunshield Chemicals to Refile Rights Issue Application Under New SEBI Regulations
Sunshield Chemicals Limited plans to withdraw its Draft Letter of Offer for a ₹200 crore rights issue and submit a fresh application under recently amended SEBI regulations. The company will hold a Board meeting on July 31, 2025, to withdraw the previous application dated September 30, 2024, and pass a fresh resolution for the rights issue. This move aims to take advantage of the simplified process introduced by SEBI, effective from April 7, 2025, without changing the previously announced rights issue terms.
Sunshield Chemicals Limited announced Q4 FY2024-25 results with revenue up 28.65% to ₹1,100.00 million, but net profit down 5% to ₹57.00 million. Annual revenue increased 29.08% to ₹36,579.00 million, while annual net profit decreased 22.66% to ₹1,457.00 million. The company declared a final dividend of ₹2.50 per share and appointed Mr. Mukesh Malhotra as an Additional Director.